Improving outcomes for colitis patients: the HALT-Colitis trial
Status: Ongoing
In this trial we will randomise patients at diagnosis to either just simple first line treatment (5 aminosalicylic acid-5ASA) or 5ASA with Faecal Microbial Transplantation (FMT). This work builds on STOP-Colitis, our previous pilot FMT study in ulcerative colitis.
Project aims
The primary aim of this trial is to see if ‘correction’ of a damaged microbiome can prevent the need for patients to escalate to advance immunomodulatory treatments.
Research projects
Advanced clinical nutrition: combining sensory perception with…
This research project was awarded the 2024 Birmingham BRC Collaboration Fund We aim…
Identifying mechanisms and druggable targets for the…
Primary sclerosing cholangitis (PSC) is a rare hepatobiliary manifestation of Inflammatory Bowel Disease…
Leucocyte and macrophage recruitment in IBD
Our team actively contributes to the advancement of research within the Adult Inflammatory…
